1 |
王丽蓉. 烧伤后创面常见的感染细菌及其药物敏感性研究[J]. 临床合理用药杂志, 2013, 6(14): 109-110.
|
2 |
韩有. 烧伤创面细菌感染患者病原菌特点及药敏分析[J]. 世界最新医学信息文摘(连续型电子期刊), 2020, 20(51): 29-30.
|
3 |
刘薇, 程翔, 梁玉龙, 等. 不同烧伤面积患者创面感染病原菌分布及其耐药性[J]. 中国感染控制杂志, 2022, 21(1): 30-36.
|
4 |
杨俊. 某院烧伤伴创面感染患者创面分泌物标本中病原菌的检出情况及其耐药性分析[J]. 抗感染药学, 2024, 21(1): 101-104.
|
5 |
康学利. 烧伤创面感染耐药分析及防治进展[J]. 首都食品与医药,2022, 29(8): 12-14.
|
6 |
KLINGER M H, JELKMANN W. Role of blood platelets in infection and inflammation[J]. Journal of interferon & cytokine research: The official journal of the International Society for Interferon and Cytokine Research, 2002, 22(9): 913-922.
|
7 |
TSCHON M, FINI M, GIARDINO R, et al. Lights and shadows concerning platelet products for musculoskeletal regeneration[J].Frontiers in bioscience (Elite edition), 2011, 3(1): 96-107.
|
8 |
MAGHSOUDI O, RANJBAR R, MIRJALILI S H, et al. Inhibitory activities of platelet-rich and platelet-poor plasma on the growth of pathogenic bacteria[J]. Iranian journal of pathology, 2017, 12(1):79-87.
|
9 |
BURNOUF T, CHOU M L, WU Y W, et al. Antimicrobial activity of platelet (PLT)-poor plasma, PLT-rich plasma, PLT gel, and solvent/detergent-treated PLT lysate biomaterials against wound bacteria[J]. Transfusion, 2013, 53(1): 138-146.
|
10 |
黄皓, 黄峻, 梁群, 等. 自体富血小板血浆治疗深二度烧伤合并感染创面的探讨—附1例报道[J]. 中国输血杂志, 2024, 37(1): 95-100.
|
11 |
刘艳波. 自体富血小板血浆凝胶在治疗烧伤残余创面的临床研究[D]. 银川:宁夏医科大学, 2017.
|
12 |
刘泉体, 高海明, 兰婷, 等. 富血小板血浆对MRSA的体外抑菌实验研究[J]. 医学理论与实践, 2019, 32(23): 3761-3763, 3780.
|
13 |
SETHI D, MARTIN K E, SHROTRIYA S, et al. Systematic literature review evaluating evidence and mechanisms of action for platelet-rich plasma as an antibacterial agent[J]. Journal of cardiothoracic surgery,2021, 16(1): 277.
|
14 |
许昌运, 宋金凤, 蔡娟. 不同保存条件的富血小板血浆对MRSA体外抑菌性研究[J]. 医学检验与临床, 2022, 33(11): 73-75.
|
15 |
LADHANI H A, YOWLER C J, CLARIDGE J A. Burn wound colonization, infection, and sepsis[J]. Surgical infections, 2021, 22(1):44-48.
|
16 |
刘炎, 何颖雨, 刘磊, 等. 富血小板血浆的抑菌作用及其机制的研究进展[J]. 临床血液学杂志, 2023, 36(6): 452-456.
|
17 |
郑勇, 秦宝磊, 宋明珠, 等. 富血小板血浆的抑菌作用及其与抗菌肽含量的关系[J]. 东南大学学报(医学版), 2023, 42(1): 139-143.
|
18 |
SMITH O J, WICAKSANA A, DAVIDSON D, et al. An evaluation of the bacteriostatic effect of platelet-rich plasma[J]. International wound journal, 2021, 18(4): 448-456.
|
19 |
D'ASTA F, HALSTEAD F, HARRISON P, et al. The contribution of leucocytes to the antimicrobial activity of platelet-rich plasma preparations: A systematic review[J]. Platelets, 2018, 29(1): 9-20.
|
20 |
DEPPERMANN C, KUBES P. Start a fire, kill the bug: The role of platelets in inflammation and infection[J]. Innate immunity, 2018,24(6): 335-348.
|
21 |
SMITH C W. Release of α-granule contents during platelet activation[J]. Platelets, 2022, 33(4): 491-502.
|
22 |
KARGARPOUR Z, PANAHIPOUR L, MIRON R J, et al. Blood clots versus PRF: Activating TGF-β signaling and inhibiting inflammation in vitro[J]. International journal of molecular sciences, 2022, 23(11):5897.
|
23 |
LIU X Y, YIN M J, LI Y, et al. Genipin modified lyophilized plateletrich fibrin scaffold for sustained release of growth factors to promote bone regeneration[J]. Frontiers in physiology, 2022, 13: 1007692.
|
24 |
KRAMER M E, KEANEY T C. Systematic review of plateletrich plasma (PRP) preparation and composition for the treatment of androgenetic alopecia[J]. Journal of cosmetic dermatology, 2018,17(5): 666-671.
|
25 |
李梦婕, 陈宁杰, 王海涛. 人富血小板血浆试管法人工制备及保存的研究进展[J]. 中国医疗美容, 2022, 12(6): 74-79.
|
26 |
洪俊, 姚锦炎, 李小文, 等. 不同方法制备的浓缩血小板表面CD62分子的表达[J]. 中国输血杂志, 2002, 15(4): 236-237.
|
27 |
MARIANI E, CANELLA V, BERLINGERI A, et al. Leukocyte presence does not increase microbicidal activity of platelet-rich plasma in vitro[J]. BMC microbiology, 2015, 15: 149.
|
28 |
LI H, HAMZA T, TIDWELL J E, et al. Unique antimicrobial effects of platelet-rich plasma and its efficacy as a prophylaxis to prevent implant-associated spinal infection[J]. Advanced healthcare materials,2013, 2(9): 1277-1284.
|
29 |
DRAGO L, BORTOLIN M, VASSENA C, et al. Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity[J]. BMC microbiology, 2013, 13: 47.
|
30 |
INTRAVIA J, ALLEN D A, DURANT T J, et al. In vitro evaluation of the anti-bacterial effect of two preparations of platelet rich plasma compared with cefazolin and whole blood[J]. Muscles, ligaments and tendons journal, 2014, 4(1): 79-84.
|